miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer. - Wikidata - wikimedia - TriplyDB

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.

http://www.wikidata.org/entity/Q38883702

about

MicroRNA aberrations: An emerging field for gallbladder cancer management Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation Long non-coding RNAs in anti-cancer drug resistance ApoptomiRs of Breast Cancer: Basics to Clinics MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion NDRG2 promotes adriamycin sensitivity through a Bad/p53 complex at the mitochondria in breast cancer.HSP90 inhibitor AUY922 can reverse Fulvestrant induced feedback reaction in human breast cancer cells MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1 Survivin contributes to DNA repair by homologous recombination in breast cancer cells.Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types.Mechanisms of doxorubicin resistance in hepatocellular carcinoma Noncoding RNAs in breast cancer.miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells.Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1.MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer.Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.HOTAIR is a promising novel biomarker in patients with thyroid cancer.LncRNA UCA1 in anti-cancer drug resistance.BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.Elucidating respective functions of two domains BIR and C-helix of human IAP survivin for precise targeted regulating mitotic cycle, apoptosis and autophagy of cancer cells.Knockdown of microRNA-29a regulates the expression of apoptosis-related genes in MCF-7 breast carcinoma cells.P53-miR-191-SOX4 regulatory loop affects apoptosis in breast cancer.MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression.Functional miRNAs in breast cancer drug resistance.

P2860

Q26768416-F3CF786E-B4D6-4A1F-B6DD-B0F56597DE3E Q28066991-056150C0-AD2B-4FF6-9088-955D76287053 Q28072366-552D6483-A685-4B2A-8AE8-2614E3EC02E4 Q28072414-1F1B18A5-F393-4B87-8D3E-EF1BC4F4FB68 Q33599411-E242CC99-C652-443A-BB22-9E63A131AD59 Q33709996-C494CA99-04D6-48F7-A250-E3345B0C96D3 Q33823200-05CFE825-A0F7-490D-879A-B8824E3E0D8B Q36341067-E6CEBEDE-0F61-4F05-97C4-13615D6F2B07 Q36441625-56DC3B30-A0D6-47AA-A923-3DCCF9725B65 Q36481398-AD5AFFE2-539C-4CBD-AA7A-B029D66940A0 Q36687760-09369944-2BE8-46C6-B483-108A9C124F43 Q36935047-C99ED11C-CCF9-4B21-8250-285C6AFE6358 Q37412557-C5A5356A-BF4D-4C6C-AE0C-D8C05B346A24 Q38291863-58436099-D0B7-49A6-9050-2E466726A9D3 Q38429163-FDB0F716-3CBE-4D0D-85D0-B524E3C3ABE7 Q38715517-55319C18-E1A6-4799-80E0-F59DBAB273C7 Q38774889-E967C41C-D377-4BFA-A210-001E06B4E23B Q41111560-D8346D8B-1DF5-48E9-B5F3-64BA6DA8E95D Q42089195-1B486A51-30BE-4B4B-B14E-5F6C4761B8F3 Q42362804-BF638115-8E4E-4056-B3E6-6FCA38FD8B59 Q48371625-3E34D9F4-D5F5-4968-AF0C-3A50237F468A Q49200938-AE3A3242-8381-473C-88B4-D0016FB78DD6 Q49590876-78F8D112-446E-439C-9223-6E002D3A51D4 Q50898952-82AB50D1-4231-449D-9F79-4F5533FE2F1B Q53394194-515630FC-09CF-4E2D-AEBA-E3F9CB28DD5C Q55000578-10229365-10B2-461D-9929-6B54F6469836

P2860

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.

http://www.wikidata.org/entity/Q38883702

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.

@en

type

label

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.

@en

prefLabel

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.

@en

P1433

Q38883702-1ACF0C1B-F41E-477D-8618-7B6BDFAB1BA8

P1476

Q38883702-497659CC-3BD6-455F-849E-392C04FE3A79

P2093

Q38883702-572FF963-1E92-4698-A78C-C39EA5BFAC40

Q38883702-C928EB18-D901-4964-BE15-6F4F060BB24E

Q38883702-FEA918E3-34B2-44A2-AC9A-A1E8B5CB2045

P2860

Q38883702-044D12D1-8322-4988-AA1B-474D99F140E2

Q38883702-0A576D0A-5D19-4C9B-8C79-71854AFE890E

Q38883702-1A962DFC-A052-4CD8-B8C6-AA164769F088

Q38883702-2431727F-0012-4FA8-8B20-AC17AFFFA75F

Q38883702-28626465-63C4-4ED2-8DA0-32EDF6227745

Q38883702-36974956-9219-4D35-9A7A-2A952FEC3746

Q38883702-3B3B577B-B32F-45DF-8CCC-318B319D422D

Q38883702-3D219CB2-9B84-4278-8934-7F14FCC8A04B

Q38883702-56F7C2F1-A64A-4BA5-A594-FD99ABCF4D1A

Q38883702-5910CE3E-CD25-4DAF-8A01-A2D82F46EE0D

P2888

Q38883702-3040078A-B569-4210-BBA5-8BCDED8C1D83

P304

Q38883702-974F4C75-6B87-4223-9D89-37FF348751C0

P31

Q38883702-00459330-7BA5-4DFC-9764-647C2B047D5D

P356

Q38883702-94FF751D-1353-4CD7-8DBA-4BAA8E808D81

P407

Q38883702-62F6B6B1-632B-4FC5-AD5D-CAAE80765799

P433

Q38883702-6FA27020-7B9F-4FF5-A8D5-6B7ECB4CB7DD

P478

Q38883702-31EABC4E-3D55-4DFA-9866-856AB3307FAD

P577

Q38883702-B7B86902-AD2E-488F-B877-D1BDB364E1DC

P6179

Q38883702-0B88AAE5-D4BF-417F-8C89-E45BC2C129C4

P698

Q38883702-69ADD17B-3DF3-44CA-97F3-120A3423610F

P921

Q38883702-F14F0314-8734-4A21-BB0D-1D4DF08102C2

P356

S10549-015-3372-9

P1433

Breast Cancer Research and Treatment

P1476

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.

@en

P2093

Ernesto Yagüe

http://www.w3.org/2001/XMLSchema#string

Kun Xu

http://www.w3.org/2001/XMLSchema#string

Yunhui Hu

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer

Control of apoptosis and mitotic spindle checkpoint by survivin

HBXIP functions as a cofactor of survivin in apoptosis suppression

miRNAs in human cancer

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

The microRNA.org resource: targets and expression

Cancer statistics, 2012

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer

Targeting survivin in cancer therapy

P2888

s10549-015-3372-9

P304

269-280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-015-3372-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015161557

http://www.w3.org/2001/XMLSchema#string

P698

25900794

http://www.w3.org/2001/XMLSchema#string

P921